Status:

UNKNOWN

Topical Application of Tranexamic Acid Reduces Postoperative Blood Loss in Total Hip Arthroplasty

Lead Sponsor:

The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

Conditions:

Hip Replacement

Postoperative Hemorrhage

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Tranexamic acid has been shown to reduce postoperative blood losses and transfusion requirements in a number of types of surgery. Most trials in orthopedic surgery have been conducted intravenously in...

Eligibility Criteria

Inclusion

  • Patient who are to undergo elective total hip arthroplasty.
  • Must be primary arthroplasty.
  • Must be single-side arthroplasty.
  • Must be older than 18 years.

Exclusion

  • Cemented arthroplasty.
  • Patients with a platelet count less than 100, 000/mm3 or history of thrombocytopenia .
  • Patients with known coagulopathy (APTT or PT outside normal range pre-operatively).
  • Patients who have a past medical history of thrombi-embolism at any time.
  • Patients with anemia (hemoglobin levels less than 8 mg/dl or hematocrit \<24%).
  • Patients with documented DVT or PE at screening or in past three months.
  • Patients having known hypersensitivity to tranexamic acid or any other. constituent of the product.
  • Patients with any associated major illness (e.g., severe cardiac \[New York Heart Association Class III or IV\] or respiratory disease).
  • Anticoagulants (other than LMWH or heparin in prophylactic doses to prevent deep vein thrombosis), direct thrombin inhibitors or thrombolytic therapy administered or completed within last week.
  • Jehovah's Witnesses, or any other group of patients with ethical objections to receiving blood products.

Key Trial Info

Start Date :

December 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT01260818

Start Date

December 1 2010

Last Update

December 1 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

the First Affiliated Hospital of Guangzhou TCM University

Guangzhou, Guangdong, China, 510405